The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Equillium, Inc. | COM | 29446K106 | 1,514,731 | 1,824,977 | SH | DFND | 1,824,977 | 0 | 0 | |||
| Ovid Therapeutics Inc. | COM | 690469101 | 6,785,000 | 5,750,000 | SH | DFND | 5,750,000 | 0 | 0 | |||
| Ovid Therapeutics Inc. | COM | 690469101 | 2,102,755 | 1,781,996 | SH | SOLE | 1,781,996 | 0 | 0 | |||
| Xilio Therapeutics, Inc. | COM | 98422T100 | 1,162,395 | 1,475,121 | SH | DFND | 1,475,121 | 0 | 0 | |||
| Turnstone Biologics Corp. | COM | 90042W100 | 498,974 | 895,824 | SH | DFND | 895,824 | 0 | 0 | |||
| Shattuck Labs, Inc. | COM | 82024L103 | 1,799,510 | 515,619 | SH | DFND | 515,619 | 0 | 0 | |||
| Wave Life Sciences Ltd. | SHS | Y95308105 | 2,050,000 | 250,000 | SH | DFND | 250,000 | 0 | 0 | |||
| Wave Life Sciences Ltd. | SHS | Y95308105 | 8,994,514 | 1,096,892 | SH | SOLE | 1,096,892 | 0 | 0 | |||
| Rani Therapeutics Holdings, Inc. | COM CL A | 753018100 | 438,890 | 203,190 | SH | DFND | 203,190 | 0 | 0 | |||
| HilleVax, Inc. | COM | 43157M102 | 11,834,640 | 6,724,000 | SH | DFND | 1 | 6,724,000 | 0 | 0 | ||
| STANDARD BIOTOOLS INC. | COM | 34385P108 | 31,874 | 16,515 | SH | DFND | 16,515 | 0 | 0 | |||
| American Well Corp | COM CL A NEW | 03044L204 | 736,913 | 77,733 | SH | DFND | 77,733 | 0 | 0 | |||